Notice of New Share Issuance for KOSDAQ Listing

Written By Sophia (Sujin) Kim

The Board of Directors of Orum Therapeutics (the "Company") resolved on October 2, 2024, to issue new shares for the purpose of listing on the KOSDAQ market. In accordance with the Korean Commercial Code and the Company's Articles of Incorporation, we hereby announce the following:

1.     Type and Number of New Shares: 3,000,000 registered common shares

  •   Public Offering: 3,000,000 shares

2.     Par Value: KRW 100 per share

3.     Issue Price: To be determined in consultation with Korea Investment & Securities Co., Ltd., the lead underwriter for the Company's KOSDAQ listing, based on the book-building results and in accordance with Article 5 (Determination of Public Offering Price of Stocks, etc.) of the Regulations on Securities Underwriting Business.

4.     Method of Subscription:

  • Shares will be allotted to third parties pursuant to Article 10, Paragraph 2, Item 8 of the Company's Articles of Incorporation.

  • The lead underwriter will be entrusted with the underwriting and public offering of the new shares.

  • The allocation of shares will be conducted in accordance with Article 9 (Stock Allocation) of the Regulations on Securities Underwriting Business.

5.     Payment Date (Expected): December 6, 2024 (Friday)

6.     Others: Other details are delegated to the Chief Executive Officer.

Orum Therapeutics

2F, 281-25 Munji-ro, Yuseong-gu, Daejeon, Republic of Korea

Sung Joo Lee,

Chief Executive Officer

Sophia (Sujin) Kim
Previous

Orum Therapeutics Selected for the 2024 Venture 100 Billion Won Companies Club by the Korean Ministry of SMEs and Startups
Next

Orum Therapeutics Submits Registration Statement for KOSDAQ Listing